# Study of DHP1401 in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil(DRAMA)

> **NCT03055741** · PHASE2 · COMPLETED · sponsor: **Daehwa Pharmaceutical Co., Ltd.** · enrollment: 180 (actual)

## Conditions studied

- Mild-moderate Alzheimer's Disease

## Interventions

- **DRUG:** Donepezil
- **DRUG:** DHP1401
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03055741
- **Lead sponsor:** Daehwa Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-28
- **Primary completion:** 2019-02
- **Final completion:** 2019-08
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2019-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03055741

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03055741, "Study of DHP1401 in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil(DRAMA)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03055741. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*